FOR IMMEDIATE RELEASE
Biosenta Inc. CSE: ZRO
DECEMBER 18, 2020 CALGARY, ALBERTA
At the request of IIROC,
Biosenta Inc. (the “Company”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.
Biosenta develops and manufactures a range of wet and dry anti-microbial chemical compounds for household and industrial applications using active material, and advanced encapsulated nanotechnology.
On December 17, 2020 Biosenta has been provided with the Notice of Allowance for the Canadian patent to be awarded for its disinfectant formulation.
Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain assumptions, estimates, and other forward-looking statements regarding future events. Such forward-looking statements involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company's control that may cause actual results or performance to differ materially from those currently anticipated in such statements.
In no way, the CSE has passed upon the contents of this news release and further has neither approved nor disapproved of the contents of this news release. Neither the CSE nor it's Regulation Services Provider (as such term is defined in the CSE) accepts responsibility for this release's adequacy or accuracy.
FOR FURTHER INFORMATION PLEASE CONTACT:
President and CEO